“…In a series from Harvard [42] , which compared 47 HCV-positive to 111 HCV-negative cases, HCV infection was an independent risk factor for the development of T2D after LT (hazard ratio 2.5, P = 0.001). These data were repeatedly confirmed by later studies [43][44][45][46][47][48][49] , with one exception from the [University of California, Los Angeles (UCLA)] series, in which the lack of association may have been a consequence of the excess representation of HCVpositive patients [50] . Several predisposing factors were identified across the studies: impaired fasting glucose and a maximum lifetime BMI over 25 kg/m 2 [49] , age and male gender [48] , serum HCV RNA level after LT [51] , and use of tacrolimus [45] or steroid boluses [43] .…”